Related Experiment Videos
Inhaled nitric oxide therapy in a critically ill neonate with Ebstein's anomaly
E Bruckheimer1, Z Bulbul, E Pinter
1Section of Pediatric Cardiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Pediatric Cardiology
|October 15, 1998
Abstract:
The successful use of nitric oxide (NO) inhalation in a critically ill neonate with Ebstein's anomaly of the tricuspid valve is reported for the first time. This use of inhaled NO therapy suggests a therapeutic intervention that directly addresses the pathophysiologic process of severe neonatal Ebstein's anomaly.